These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24626060)

  • 1. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
    Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC
    Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of interstitial fibrosis and tubular atrophy in kidney allograft: implementation of microRNAs.
    Zununi Vahed S; Samadi N; Ardalan M
    Iran J Kidney Dis; 2014 Jan; 8(1):4-12. PubMed ID: 24413714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
    Hart A; Jackson S; Kasiske BL; Mauer MS; Najafian B; Matas AJ; Spong R; Ibrahim HN
    Transplantation; 2014 May; 97(10):1066-71. PubMed ID: 24503762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy.
    Akioka Y; Chikamoto H; Horita S; Yago R; Tanabe K; Yamaguchi Y; Hattori M
    Clin Transplant; 2009 Aug; 23 Suppl 20():2-5. PubMed ID: 19594587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Exp Clin Transplant; 2014 Aug; 12(4):314-22. PubMed ID: 25095709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-bet-positive mononuclear cell infiltration is associated with transplant glomerulopathy and interstitial fibrosis and tubular atrophy in renal allograft recipients.
    Yadav B; Prasad N; Agrawal V; Jain M; Agarwal V; Jaiswal A; Bhadauria D; Sharma RK; Gupta A
    Exp Clin Transplant; 2015 Apr; 13(2):145-51. PubMed ID: 25871366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
    Scherer A; Gwinner W; Mengel M; Kirsch T; Raulf F; Szustakowski JD; Hartmann N; Staedtler F; Engel G; Klupp J; Korn A; Kehren J; Haller H
    Nephrol Dial Transplant; 2009 Aug; 24(8):2567-75. PubMed ID: 19398767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragraft tubular vimentin and CD44 expression correlate with long-term renal allograft function and interstitial fibrosis and tubular atrophy.
    Kers J; Xu-Dubois YC; Rondeau E; Claessen N; Idu MM; Roelofs JJ; Bemelman FJ; ten Berge IJ; Florquin S
    Transplantation; 2010 Sep; 90(5):502-9. PubMed ID: 20588206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
    Nogare AL; Veronese FV; Carpio VN; Montenegro RM; Pedroso JA; Pegas KL; Gonçalves LF; Manfro RC
    BMC Nephrol; 2015 Feb; 16():19. PubMed ID: 25884518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial fibrosis and tubular atrophy in renal allograft protocol biopsies as a surrogate of graft survival.
    Serón D
    Transplant Proc; 2009 Mar; 41(2):769-70. PubMed ID: 19328976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK; Weir MR
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive interstitial fibrosis of kidney allograft early after transplantation from a non-heart beating donor: possible role of persistent ischemic injury.
    Masutani K; Kitada H; Yamada S; Tsuchimoto A; Noguchi H; Tsuruya K; Katafuchi R; Tanaka M; Iida M
    Clin Transplant; 2010 Jul; 24 Suppl 22():70-4. PubMed ID: 20590699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.
    Modena BD; Kurian SM; Gaber LW; Waalen J; Su AI; Gelbart T; Mondala TS; Head SR; Papp S; Heilman R; Friedewald JJ; Flechner SM; Marsh CL; Sung RS; Shidban H; Chan L; Abecassis MM; Salomon DR
    Am J Transplant; 2016 Jul; 16(7):1982-98. PubMed ID: 26990570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction.
    Strutz F
    Clin Transplant; 2009 Dec; 23 Suppl 21():26-32. PubMed ID: 19930313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts.
    Zhou HL; Wang YT; Gao T; Wang WG; Wang YS
    Transplant Proc; 2013 Mar; 45(2):538-45. PubMed ID: 23498789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.